# Aprea Therapeutics, Inc.: Form 8-K, filed Jan 23, 2026

- Company: [Aprea Therapeutics, Inc.](/companies/apre.md) (CIK 1781983)
- Form: 8-K
- Filed: 2026-01-23
- Accepted by EDGAR: Jan 23, 2026, 16:45 ET
- Period: 2026-01-23
- Accession: 0001104659-26-006267
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1781983/000110465926006267/tm263963d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781983/000110465926006267/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1781983/000110465926006267/tm263963d1_8k.htm

Filed Jan 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-006267. Last ingested by Listed: Nov 4, 2026, 08:47 ET. No prices; not investment advice.